Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence

Exp Clin Psychopharmacol. 2005 Nov;13(4):293-302. doi: 10.1037/1064-1297.13.4.293.

Abstract

This study examined (1) predictors of treatment outcome for opioid-dependent participants in a single-site controlled trial comparing methadone, buprenorphine, and LAAM treatments and (2) the extent to which various subpopulations of patients may have more successful outcomes with each medication. The relationships between patient demographics, drug use history, and psychological status and outcome measures of treatment retention, opiate use, and cocaine use were assessed. We believe this study to be the first to demonstrate that predictors of treatment success appear to be largely similar in LAAM, buprenorphine, and methadone treatment for opioid dependence. We did not find any factors that would strongly guide selection of one medication over others.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Analgesics, Opioid / pharmacology
  • Analgesics, Opioid / therapeutic use*
  • Buprenorphine / pharmacology
  • Buprenorphine / therapeutic use
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Methadone / pharmacology
  • Methadone / therapeutic use
  • Methadyl Acetate / pharmacology
  • Methadyl Acetate / therapeutic use
  • Middle Aged
  • Opioid-Related Disorders / drug therapy*
  • Prospective Studies
  • Receptors, Opioid, mu / agonists
  • Regression Analysis
  • Treatment Outcome

Substances

  • Analgesics, Opioid
  • Receptors, Opioid, mu
  • Buprenorphine
  • Methadyl Acetate
  • Methadone